marijuana stock news

NTRR: New Congressional Bills Could End Federal Prohibition of Cannabis

As Neutra Corp. (NTRR) continues to develop new products to serve the fast-growing U.S. cannabis industry, two new bills were introduced to Congress last week that could put cannabis on the fast track to nationwide legalization.

U.S. Rep. Jared Polis’ (D-CO) Regulate Marijuana Like Alcohol Act proposes to legalize cannabis without fear of federal intervention, while Rep. Earl Blumenauer’s (D-OR) Marijuana Tax Revenue Act seeks to tax cannabis sales at the federal and state level.

The new legislation is only the latest sign of shifting attitudes toward cannabis consumption in the U.S., where the majority of Americans support repealing criminalization to boost tax income and lower crime rates. If passed, the new bills will make adult access to cannabis hassle-free, increasing NTRR’s value in the industry.

“This is huge news for companies like ours that are developing products for this industry,” said NTRR CEO Chris Brown. “As fast as demand has grown for cannabis-related products in recent years, it is certain to skyrocket if the Federal government effectively legalizes the plant. Congress is now on the cusp of making that vision a reality, and NTRR will be there to capitalize by serving the emerging needs of a massive new consumer group.”

The bills will be heard before Congress in the latest term.

NTRR has already taken measures to position itself as a leader in the U.S. cannabis market by marketing and developing new indoor horticultural innovations to make cannabis cultivation easier and more efficient than ever before. Last week, the company announced that its joint venture partner, Vertigo Technologies, Inc., sold its first self-contained, indoor horticulture system to a California cultivator.

About Neutra Corp.

Neutra Corp. is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-related products. By providing a variety of new technologies designed to ensure safer, more reliable access to cannabis in approved markets, Neutra Corp. plans to compete alongside GW Pharmaceuticals (GWPRF), INSYS Therapeutics, Inc. (INSY) and ENDEXX Corp. (EDXC), delivering technological advancements in the cultivation and processing of cannabis in approved markets. For investing information and performance data, please visit

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone’s past success, either financial or strategic, is no guarantee of success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.

Neutra Corp.
Chris Brown, 813-367-2041
President and CEO

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 |
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$VHUB Launches New Marketing Campaign

Vapor Hub International Launches New Marketing Campaign SIMI VALLEY, Calif., March 17,…

$CBIS Form 10-Q/A

Form 10-Q/A for CANNABIS SCIENCE, INC. 24-Nov-2015 Quarterly Report ITEM 2. MANAGEMENT’S…

Sundial Growers Inc. (SNDL) and Alcanna Inc. Announce the Agreement to Revised Consideration

Sundial Growers and Alcanna Inc. Announce the Agreement to Revised Consideration Under…

$ATTBF Appoints Hugh Oswald as Investor Relations

Abattis Appoints Hugh Oswald as Investor Relations  Abattis Bioceuticals Corp. (the “Company”…